Cosentyx (secukinumab) starts working within the first few weeks, but most people notice meaningful improvement between weeks 3 and 16 depending on the condition being treated. The medication works by blocking a specific inflammatory protein called IL-17A, and the loading dose schedule (weekly injections for the first five weeks) is designed to build up drug levels quickly. Full results, however, take longer to appear.
How Cosentyx Works
Cosentyx is a biologic that selectively binds to IL-17A, an inflammatory protein that drives skin cell overproduction, joint inflammation, and tissue damage in autoimmune conditions. By neutralizing IL-17A, Cosentyx interrupts the cycle of inflammation without broadly suppressing your immune system. At therapeutic doses, it fully neutralizes IL-17A activity while leaving other immune functions intact.
The downstream effects of blocking IL-17A happen in stages. Inflammatory gene activity drops as early as week 4, but visible changes to skin, joints, or spine take longer because damaged tissue needs time to heal and turn over.
The Loading Dose Schedule
For most conditions, Cosentyx follows the same initial pattern: one injection per week at weeks 0, 1, 2, 3, and 4, then one injection every four weeks after that. This front-loaded schedule saturates your system with the drug faster than monthly dosing alone would. For plaque psoriasis, the standard dose is 300 mg at each injection. For psoriatic arthritis and ankylosing spondylitis, the starting dose is typically 150 mg, though your doctor may increase to 300 mg if the response isn’t adequate.
For hidradenitis suppurativa, the dose is 300 mg with the same loading schedule, and if the response is insufficient, dosing can be increased to every two weeks rather than every four.
Timeline for Plaque Psoriasis
Psoriasis patients tend to see the fastest response. In clinical trials, people on the 300 mg dose reached a 50% reduction in their psoriasis severity score in a median of just 3 weeks. Those on 150 mg hit the same milestone at about 3.9 weeks. For comparison, patients taking etanercept (a different biologic) took 7 weeks to reach the same point.
That said, a 50% improvement is noticeable but not the finish line. Peak results for psoriasis typically arrive around week 16, and clinical trial data shows those results hold steady through at least 52 weeks of continued treatment. So while you may see encouraging changes in your skin within the first month, the full effect takes closer to four months.
Timeline for Psoriatic Arthritis
Joint improvements from Cosentyx follow a somewhat slower curve than skin improvements. The key milestone in clinical trials was the proportion of patients achieving at least a 20% improvement in joint symptoms at week 24 (about six months). In the FUTURE 2 trial, which studied 397 patients, Cosentyx produced rapid early improvements, but the primary measure of success was assessed at week 24, with benefits sustained through two years of treatment.
In practical terms, many people with psoriatic arthritis notice reduced joint stiffness and swelling within the first couple of months, but it can take up to six months to see the drug’s full effect on joint pain and function. If you also have psoriasis alongside your joint disease, skin symptoms will likely improve before joint symptoms do.
Timeline for Ankylosing Spondylitis
Spinal inflammation responds to Cosentyx surprisingly quickly. In a phase III trial of patients with axial spondyloarthritis, overall disease activity scores improved compared to placebo as early as week 1. By the end of the study period, patients on Cosentyx showed significant improvements in pain, stiffness, and spinal mobility, with early gains sustained through 52 weeks.
That week-1 signal doesn’t mean you’ll feel dramatically better after a single injection, but it does suggest the inflammatory process begins to quiet down almost immediately. Most patients with ankylosing spondylitis can expect noticeable improvements in morning stiffness and back pain within the first four to six weeks, with continued gains over several months.
Timeline for Hidradenitis Suppurativa
Cosentyx was more recently approved for hidradenitis suppurativa (HS), and the timeline here is measured a bit differently. The primary endpoint in the SUNSHINE and SUNRISE trials was a clinical response at week 16, defined as at least a 50% reduction in abscesses and inflammatory nodules without new draining tunnels forming. In the SUNSHINE trial, 45% of patients on the every-two-week dosing schedule met this threshold at 16 weeks, compared to 34% on placebo.
Responses continued to build, with benefits sustained through 52 weeks. If you have HS, expect to wait at least three to four months before judging whether Cosentyx is working for you.
Why Body Weight Affects Response Time
One factor that consistently influences how quickly Cosentyx works is body weight. A real-world study of psoriasis patients found that those with a BMI under 30 were significantly more likely to achieve a 90% improvement in skin symptoms at both 12 and 24 weeks compared to those with a BMI of 30 or higher (55% vs. 43% at week 12, and 67% vs. 57% at week 24). When researchers controlled for other variables like age, sex, and disease severity, BMI was the only factor that significantly predicted response speed for Cosentyx.
This doesn’t mean the drug won’t work if you have a higher BMI. It means it may take longer to reach peak effectiveness, and your doctor may consider the 300 mg dose even for conditions where 150 mg is the usual starting point.
Interestingly, baseline disease severity did not affect how likely patients were to respond. Whether your psoriasis is moderate or severe at the start, your odds of reaching a strong response at 12 or 24 weeks are similar. Previous use of other biologics also did not significantly impact Cosentyx response speed, unlike some other medications where prior biologic exposure reduces effectiveness.
What to Expect Month by Month
During the first month, you’re receiving weekly loading doses. Some people notice reduced redness, less scaling, or slight improvements in joint stiffness during this window. For spinal conditions, early relief from morning stiffness is possible within the first few weeks.
By months two and three, improvements become more obvious. Psoriasis plaques thin and fade, joint swelling decreases, and energy levels often improve as systemic inflammation drops. This is the period when most people feel confident the medication is doing something.
Months four through six is when Cosentyx approaches peak effectiveness for most conditions. Psoriasis patients typically see their best skin around week 16. Psoriatic arthritis patients often reach their best joint function closer to week 24. If you haven’t seen meaningful improvement by month six, your doctor will likely reassess the treatment plan, potentially increasing the dose before considering a switch.
After six months, the goal shifts from building a response to maintaining it. Clinical data consistently shows that people who respond to Cosentyx tend to maintain that response through at least one to two years of continued treatment.